Propanc Biopharma (PPCB) Net Income towards Common Stockholders (2011 - 2025)
Propanc Biopharma (PPCB) reported Net Income towards Common Stockholders of -$19.79 million for FY2026 (year ended Jun 30, 2026), compared with -$58.92 million in FY2025.
Powered by 
Analysis
Propanc Biopharma (PPCB) Net Income towards Common Stockholders (2011 - 2025) Analysis & Trends
Dating back to FY2011, Propanc Biopharma's Net Income towards Common Stockholders record includes 16 fiscal years.
- Five-year annual Net Income towards Common Stockholders spans a low of -$58.92 million in FY2025 and a high of -$2.01 million in FY2024.
- According to Business Quant data, Net Income towards Common Stockholders came in at -$58.92 million in FY2025, -$2.01 million in FY2024, -$3.13 million in FY2023 and -$3.36 million in FY2022.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Income (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn | 7.10 Bn |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn | 5.53 Bn |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn | 3.61 Bn |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn | -1.34 Bn |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn | 3.26 Bn |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn | 2.89 Bn |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn | 2.38 Bn |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn | -10.50 Bn |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn | -248.00 Mn |
| 10 | Propanc Biopharma | 573,091.58 | 573,091.58 | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | -4.02 Mn |
| Sep 30, 2025 | -4.84 Mn |
| Jun 30, 2025 | -4.07 Mn |
| Mar 31, 2025 | -54.07 Mn |
| Dec 31, 2024 | -430,183.00 |
| Sep 30, 2024 | -354,310.00 |
| Jun 30, 2024 | -358,578.00 |
| Mar 31, 2024 | -542,500.00 |
| Dec 31, 2023 | -618,969.00 |
| Sep 30, 2023 | -493,441.00 |
| Jun 30, 2023 | -805,760.00 |
| Mar 31, 2023 | -809,809.00 |
| Dec 31, 2022 | -504,740.00 |
| Sep 30, 2022 | -1.01 Mn |
| Jun 30, 2022 | -1.16 Mn |
| Mar 31, 2022 | -700,076.00 |
| Dec 31, 2021 | -893,375.00 |
| Sep 30, 2021 | -605,502.00 |
| Jun 30, 2021 | -1.17 Mn |
| Mar 31, 2021 | -417,738.00 |
API Access
Propanc Biopharma Net Income towards Common Stockholders API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=net-income-towards-common-stockholders&ticker=PPCB&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "net-income-towards-common-stockholders", "ticker": "PPCB", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=net-income-towards-common-stockholders&ticker=PPCB&period=max&api_key=YOUR_API_KEY");
const data = await res.json();